Researchers have identified smac mimetics as a class of cancer drugs that synergized with histone deacetylase (HDAC) inhibitors to flush HIV out of hiding in infected T cells. The results suggest that smac mimetics could help achieve one of the major goals of current HIV research – an eradication cure.